Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuous nasogastric morphine infusion.

M C Ingebretson1, F Pucino, C L Beck

  • 1Veterans Administration Medical Center, Fargo, ND.

Drug Intelligence & Clinical Pharmacy
|October 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Osteoid osteoma.

Orthopedics·2014
Same author

RFLP and RAPD mapping of the rice gm2 gene that confers resistance to biotype 1 of gall midge (Orseolia oryzae).

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

DNA markers tightly linked to a gall midge resistance gene (Gm2) are potentially useful for marker-aided selection in rice breeding.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis.

Alimentary pharmacology & therapeutics·2011
Same author

Hormonal changes throughout the menstrual cycle and increased anterior cruciate ligament laxity in females.

Journal of athletic training·2006
Same author

Inhibition of the A-type K+ channels of dorsal root ganglion neurons by the long-duration anesthetic butamben.

The Journal of pharmacology and experimental therapeutics·2005
Same journal

Profile of prescription medication in a pediatric population.

Drug intelligence & clinical pharmacy·1988
Same journal

SI units in drug therapeutics.

Drug intelligence & clinical pharmacy·1988
Same journal

Physicians' review of significant interventions by clinical pharmacists in inpatient care.

Drug intelligence & clinical pharmacy·1988
Same journal

Possible interaction of ranitidine with phenytoin.

Drug intelligence & clinical pharmacy·1988
Same journal

Famotidine-associated mental confusion in elderly patients.

Drug intelligence & clinical pharmacy·1988
Same journal

Intravenous self-administration of elemental mercury: efficacy of dimercaprol therapy.

Drug intelligence & clinical pharmacy·1988
See all related articles

A new method safely converted a terminally ill patient from intravenous to nasogastric morphine for severe pain management. This approach benefits patients needing continuous enteral nutrition and high-dose opioid therapy.

Area of Science:

  • Palliative Care
  • Pharmacology
  • Oncology

Background:

  • Morphine sulfate is a primary analgesic for terminally ill patients.
  • Effective pain management is crucial in advanced cancer care.
  • Continuous administration routes are often necessary for consistent pain control.

Observation:

  • A 56-year-old patient with metastatic lung cancer experienced severe pain.
  • The patient required continuous nasogastric feeding and around-the-clock opioid analgesics.
  • Oral administration was not feasible for this patient.

Findings:

  • A novel method successfully converted the patient's pain management from intravenous morphine to continuous nasogastric morphine.
  • This administration route was integrated with existing nasogastric enteral feedings.

Related Experiment Videos

  • The conversion was achieved safely and effectively, managing severe pain.
  • Implications:

    • Continuous nasogastric morphine administration offers a viable alternative for patients on enteral tube feedings.
    • This method may be beneficial for terminally ill patients requiring high-dose opioid therapy.
    • It provides an alternative for patients unable to use oral pain medication routes.